Sunfish Poland I

Sunfish Partners is a venture capital firm founded in 2016, with headquarters in Berlin, Germany, and an additional office in Warsaw, Poland. The firm specializes in early-stage investments, particularly in the pre-seed and seed stages, focusing on deep tech startups. Sunfish Partners primarily targets investments in sectors such as healthcare, software, hardware, and business products and services. The firm typically invests between 1 million PLN and 3 million PLN in its portfolio companies, emphasizing opportunities in Polish firms while also exploring potential throughout Central and Eastern Europe.

Marcus Erken

Co-Founder, Managing Partner and Managing Director

Pawel Lipkowski

CFO and Operating Partner

Max Moldenhauer

Co-Founder, Managing Partner and Managing Director

11 past transactions

Pergamin

Seed Round in 2022
Pergamin sp. z o.o. is a Polish company based in Warsaw, founded in 2017, that specializes in providing a platform for the creation and management of legal documents and contracts specifically designed for medium and small enterprises. The platform facilitates the entire contracting process, allowing users to create modular templates, negotiate contracts, and sign them electronically in a single, user-friendly tool. It also offers management features that enable users to monitor the status of contracts, generate additional documents, and access a cloud-based repository for reviewing past agreements. By digitalizing the contract process, Pergamin enhances efficiency, reduces costs, and streamlines various business operations through improved data sharing and integration with other systems within an organization.

Alphamoon

Seed Round in 2022
Alphamoon is a company focused on transforming industries through the development of advanced AI solutions. Its primary offering is a document automation and data extraction platform that enhances the debt recovery process. By automating document processing, Alphamoon significantly reduces both the time and cost associated with handling documents, allowing clients to efficiently extract valuable data. The company aims to improve overall performance by minimizing human-dependent errors and accelerating routine tasks, providing expertise that spans from basic reasoning engines to comprehensive web and mobile applications.

Scramjet

Seed Round in 2022
Developer of open-source cloud software designed for efficient transformation of data-in-motion. The company's platform combines three trending technologies efficiency of stream processing, the agility of serverless cloud computing, and the flexibility of edge or fog computing, enabling companies from automotive and IoT to Machine Learning and Business Intelligence.

Aether Biomedical

Seed Round in 2021
Aether Biomedical Sp. z o.o operates as a medical robotics company focused on bio signal processing and bionic limbs for upper limb amputees. It offers a product Zeus, a multi-action bionic limb combining ease of control and can be used without any additional coverage or with a silicone glove. The company was founded in 2016 and is based in Poznan, Poland.

Molecule.one

Seed Round in 2021
Molecule One sp. z o.o. develops and markets an application software for synthetic chemists. The company's products include M1 Builder, which is a web-based customizable tool for molecule drawing; M1 Analyst, which is a tool for fetching and bringing together all the information crucial to synthesis planning about a molecule; and M1 Architect, which is synthesis planner for molecule builder. Molecule One sp. z o.o. was incorporated in 2016 and is headquartered in Warsaw, Poland.

Solvemed

Pre Seed Round in 2020
At Solvemed Group, we believe in challenging the status quo of neurological care. Our founders experienced first-hand the grave consequences of poor diagnostic standards in neurodegenerative diseases. With the primary focus in Parkinson’s disease, we leverage our proprietary machine learning technology to develop novel diagnostic-predictive digital biomarkers to enable first-in-class, accurate, early and cost-effective diagnostic and monitoring tools. In everything we do, we put the needs of patients and healthcare professionals first. We also happen to revolutionise drug discovery as our biomarkers enable disease-modifying drugs. We respond to the unmet needs of neurological patients by providing reliable, accurate, early diagnostics and monitoring tools for better quality care and treatment outcomes. Our work has the potential to improve healthcare systems by optimising relevant care pathways and reducing the financial burden imposed by inadequate diagnostics. Through our proprietary medical data repositories, we work with our biopharmaceutical industry partners driving clinical trial efficiency and making first-in-class disease-modifying drugs possible. Everything we do is strongly embedded in world-class science. Our global team of renowned scientists and technology experts works closely with clinical researchers from top research institutions, such as Oxford University, University College London, Harvard Medical School and Duke University, among other.

Aether Biomedical

Seed Round in 2020
Aether Biomedical Sp. z o.o operates as a medical robotics company focused on bio signal processing and bionic limbs for upper limb amputees. It offers a product Zeus, a multi-action bionic limb combining ease of control and can be used without any additional coverage or with a silicone glove. The company was founded in 2016 and is based in Poznan, Poland.

Perfops

Seed Round in 2019
PerfOps is a company based in Krakow, Poland, founded in 2017, that offers a network analytics platform designed to enhance the monitoring of global and distributed network applications. Its suite of products includes FlexBalancer, a cloud-based load-balancing service that optimizes internet traffic routing based on performance and cost parameters. The platform also features PerfOps CLI, a command line tool for executing network tests, and PerfOps Network Utilities, which provides a control panel for various network utilities. Additionally, PerfOps Analytics delivers insights into CDN, DNS, and cloud performance, utilizing a vast dataset from billions of benchmarks. With a network of 300 global servers, the company facilitates on-demand network testing and debugging, enabling businesses to gain comprehensive visibility into their network performance and address potential issues effectively.

Molecule.one

Pre Seed Round in 2019
Molecule One sp. z o.o. develops and markets an application software for synthetic chemists. The company's products include M1 Builder, which is a web-based customizable tool for molecule drawing; M1 Analyst, which is a tool for fetching and bringing together all the information crucial to synthesis planning about a molecule; and M1 Architect, which is synthesis planner for molecule builder. Molecule One sp. z o.o. was incorporated in 2016 and is headquartered in Warsaw, Poland.

Perfops

Seed Round in 2018
PerfOps is a company based in Krakow, Poland, founded in 2017, that offers a network analytics platform designed to enhance the monitoring of global and distributed network applications. Its suite of products includes FlexBalancer, a cloud-based load-balancing service that optimizes internet traffic routing based on performance and cost parameters. The platform also features PerfOps CLI, a command line tool for executing network tests, and PerfOps Network Utilities, which provides a control panel for various network utilities. Additionally, PerfOps Analytics delivers insights into CDN, DNS, and cloud performance, utilizing a vast dataset from billions of benchmarks. With a network of 300 global servers, the company facilitates on-demand network testing and debugging, enabling businesses to gain comprehensive visibility into their network performance and address potential issues effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.